BP000756-ENZ-269: Recombinant Lysostaphin
Source: E. coli-derived.
Determined by the decrease in turbidity of a suspension of heat-killed Staphylococcus aureus at pH8.0, 30C.
Purity > 95%, by SDS-PAGE.BP000653-ENZ-076: Recombinant Human Acyl-Protein Thioesterase 2 (LYPLA2) Enzyme
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP001616-PRO-259: Recombinant Human U6 snRNA-Associated Sm-Like Protein LSm1 (LSM1) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000651-ENZ-086: Recombinant Human Lipoprotein Lipase
Source: E. coli-derived.BP000651-ENZ-087: Recombinant Human Lipoprotein Lipase, HEK
Source: HEK293 (Human Embryonic Kidney cell line)-derived.
Applications: WB.BP000764-ENZ-408: Recombinant Human Low Molecular Weight Phosphotyrosine Protein Phosphatase (LMW-PTP) Enzyme
Source: E. coli-derived.
Specific Activity: 60,000 Units per 1 mg.
Purity: > 95% by SDS-PAGE.BP000221-CYT-683: Human Leptin
Source: E. Coli-derived.
Purity > 95.0% by RP-HPLC.BP000221-CYT-531: Recombinant Ovine Leptin, MTS tag
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor.
Purity > 98.0% by reducing SDS?PAGE and SEC-HPLC.BP000221-CYT-591: Recombinant Mouse Pegylated Leptin
Source: E. Coli-derived.
Pegylated mouse Leptin is capable of stimulatng proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Pegylated mouse Leptin in vitro activity is only slightly lower than the non-pegylated antagonist but in vivo it has profound weight reducing effect (as compared to the non-pegylated leptin), resulting mainly from reduced food intake.
Purity > 99.0% by Gel-Filtration and SDS?PAGE.BP000221-CYT-505: Recombinant Chicken Leptin (LEP) Protein
Source: E. Coli-derived.
Biological active as evidenced by inducing proliferation of BAF/3 cells stably transfected with the long form of human leptin receptor. Its activity is however 5-10 fold lower as compared to mammalian leptins.
Purity: > 95.0% by reducing SDS?PAGE and SEC-HPLC.